Skip to main content
Premium Trial:

Request an Annual Quote

JGI Purchases $500K Sequencing System from 454

NEW YORK, Aug. 1 (GenomeWeb News) - The US Department of Energy's Joint Genome Institute has purchased a $500,000 genome sequencing system from 454 Life Sciences, an institute official said today.

 

454, a subsidiary of CuraGen, has developed a system that accelerates sequencing processes through the use of microfluidics and other methods of miniaturizing current technology. Previously, the Brandford, Conn.-based company offered use of the system as a service.

 

In March, GenomeWeb News reported that 454 had installed the first system at HarvardUniversity's and MIT's Broad Institute.

 

454 recently described its sequencing technology in a paper in the July 31 online issue of Nature. In the paper, researchers from the company used the system to re-sequence 580,069 bases of the genome of the bacterium Mycoplasma genitalium in one four-hour run with up to 99.99 percent accuracy -- a 100-fold increase in throughput over current sequencing technology, according to the company.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.